CardioSecur presents the easiest to use 12+ lead mobile ECG at the Digital Healthcare Show in London
The German MedTech company will showcase its unprecedented 12+ lead ECG with only 4 electrodes at the Digital Healthcare…
The German MedTech company will showcase its unprecedented 12+ lead ECG with only 4 electrodes at the Digital Healthcare…
Global industry analyst firm KuppingerCole Analysts celebrated the winners of the prestigious 2022 European Identity Awa…
4SC AG (4SC, FSE Prime Standard: VSC) today announced the results of a scheduled review of 4SC’s program for the clinica…
First Patient Enrolled in TURANDOT Study Evaluating Domatinostat in the Neoadjuvant Setting in Urothelial Carcinoma Comb…
. - MERKLIN1 study progress update - EMERGE phase IIa clinical data presentation - DONIMI phase Ib clinical data presen…
* MERKLIN1: Trial in progress e-poster (ID 123) and oral presentation entitled "A phase II, open label, multicenter stud…
– Received FDA Clearance to Initiate Twin IMU-838 Phase 3 ENSURE Trials in Relapsing-Remitting Multiple Sclerosis and Su…
. – IMU- 935 Has Been Observed In Vitro to Inhibit the Generation of Th17 Cells and Production of IL-17 Cytokines Withou…
4SC today announced the initiation of a second clinical collaboration with the Netherlands Cancer Institute (NKI) on a p…
Prof. Dr. Jessica C. Hassel, Principle Investigator of the SENSITIZE study at the University Hospital Heidelberg, German…